Spesialistsenteret Pilestredet Park
- Address
- Pilestredet Park 12A, 0176 Oslo, Norway
Spesialistsenteret Pilestredet Park - Endocrine & Metabolic Disorders
Spesialistsenteret Pilestredet Park is a specialized clinical research center with demonstrated expertise in endocrine disorders and metabolic bone diseases. The center participates in advanced therapeutic studies focused on rare hormonal conditions affecting calcium and mineral metabolism.
- Hypoparathyroidism treatment and hormone replacement therapies
- Calcium homeostasis and parathyroid hormone regulation studies
- Novel subcutaneous therapies for endocrine deficiency disorders
The center's research activities include participation in international multicenter trials evaluating innovative treatment approaches for hypoparathyroidism, a rare condition characterized by inadequate parathyroid hormone production. Their involvement in studies of TransCon PTH demonstrates expertise in assessing complex endpoints including serum and urinary calcium levels, fractional excretion of calcium, and optimization of active vitamin D and calcium supplementation regimens in adult patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spesialistsenteret Pilestredet Park
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Subcutaneous Palopegteriparatide in Adults with Hypoparathyroidism: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial | Ascendis Pharma Bone Diseases A/S | Phase II | Not Recruiting | Sep 2019 | Mar 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Palopegteriparatide | 1 | Unknown | 2019-09-03 | 2019-09-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.